首页> 美国卫生研究院文献>Applied and Environmental Microbiology >Recombinant Environmental Libraries Provide Access to Microbial Diversity for Drug Discovery from Natural Products
【2h】

Recombinant Environmental Libraries Provide Access to Microbial Diversity for Drug Discovery from Natural Products

机译:重组环境图书馆提供了微生物多样性的途径可用于从天然产物中发现药物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To further explore possible avenues for accessing microbial biodiversity for drug discovery from natural products, we constructed and screened a 5,000-clone “shotgun” environmental DNA library by using an Escherichia coli-Streptomyces lividans shuttle cosmid vector and DNA inserts from microbes derived directly (without cultivation) from soil. The library was analyzed by several means to assess diversity, genetic content, and expression of heterologous genes in both expression hosts. We found that the phylogenetic content of the DNA library was extremely diverse, representing mostly microorganisms that have not been described previously. The library was screened by PCR for sequences similar to parts of type I polyketide synthase genes and tested for the expression of new molecules by screening of live colonies and cell extracts. The results revealed new polyketide synthase genes in at least eight clones. In addition, at least five additional clones were confirmed by high-pressure liquid chromatography analysis and/or biological activity to produce heterologous molecules. These data reinforce the idea that exploiting previously unknown or uncultivated microorganisms for the discovery of novel natural products has potential value and, most importantly, suggest a strategy for developing this technology into a realistic and effective drug discovery tool.
机译:为了进一步探索从天然产物中获取微生物多样性以获取药物发现途径的可能途径,我们使用大肠杆菌-链霉菌利维丹穿梭粘粒载体和直接来自微生物的DNA插入片段构建了并筛选了5,000个克隆的“ shot弹枪”环境DNA文库。栽培)。通过几种方法对该文库进行了分析,以评估多样性,遗传含量和两个表达宿主中异源基因的表达。我们发现,DNA文库的系统发育内容极为多样,主要代表以前未描述的微生物。通过PCR筛选该文库中与I型聚酮化合物合酶基因部分相似的序列,并通过筛选活菌落和细胞提取物测试新分子的表达。结果揭示了至少八个克隆中有新的聚酮化合物合酶基因。另外,通过高压液相色谱分析和/或产生异源分子的生物学活性,证实了至少五个另外的克隆。这些数据强化了这样一种观念,即利用先前未知或未经培养的微生物来发现新的天然产物具有潜在价值,最重要的是,提出了将这项技术发展为现实有效的药物发现工具的策略。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号